Your session is about to expire
← Back to Search
Other
Creatine Monohydrate for Depression
Phase 4
Waitlist Available
Led By Perry F Renshaw, MD, PhD, MBA
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will test whether a dietary supplement can help reduce the severity of depression in people with type 2 diabetes.
Eligible Conditions
- Depression
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change from Baseline in Hamilton Depression Rating Scale
Trial Design
1Treatment groups
Experimental Treatment
Group I: Open Label Treatment with CreatineExperimental Treatment1 Intervention
5 grams daily of oral creatine monohydrate powde
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Creatine
FDA approved
Find a Location
Who is running the clinical trial?
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,707 Total Patients Enrolled
23 Trials studying Depression
2,402 Patients Enrolled for Depression
Perry F Renshaw, MD, PhD, MBAPrincipal InvestigatorUniversity of Utah
3 Previous Clinical Trials
175 Total Patients Enrolled
2 Trials studying Depression
71 Patients Enrolled for Depression
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger